azacyclonol has been researched along with Cancer of Prostate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Awasthi, BP; Chaudhary, P; Dahal, S; Jeong, BS; Karmacharya, U; Kim, JA; Lim, D; Park, HD | 1 |
1 other study(ies) available for azacyclonol and Cancer of Prostate
Article | Year |
---|---|
Synthesis and anticancer evaluation of 6-azacyclonol-2,4,6-trimethylpyridin-3-ol derivatives: M3 muscarinic acetylcholine receptor-mediated anticancer activity of a cyclohexyl derivative in androgen-refractory prostate cancer.
Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; Piperidines; Prostatic Neoplasms; Pyridines; Receptor, Muscarinic M3; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |